162 related articles for article (PubMed ID: 36070106)
61. Tumor angiogenesis of SCLC inhibited by decreased expression of FMOD via downregulating angiogenic factors of endothelial cells.
Ao Z; Yu S; Qian P; Gao W; Guo R; Dong X; Xu J; Zhang R; Jiang C; Ji F; Qian G
Biomed Pharmacother; 2017 Mar; 87():539-547. PubMed ID: 28081464
[TBL] [Abstract][Full Text] [Related]
62. Epithelial to mesenchymal transition in arsenic-transformed cells promotes angiogenesis through activating β-catenin-vascular endothelial growth factor pathway.
Wang Z; Humphries B; Xiao H; Jiang Y; Yang C
Toxicol Appl Pharmacol; 2013 Aug; 271(1):20-9. PubMed ID: 23643801
[TBL] [Abstract][Full Text] [Related]
63. Growth factors VEGF and TGF-beta1 in peritoneal dialysis.
Zweers MM; de Waart DR; Smit W; Struijk DG; Krediet RT
J Lab Clin Med; 1999 Aug; 134(2):124-32. PubMed ID: 10444025
[TBL] [Abstract][Full Text] [Related]
64. Vasohibin-1 expression inhibits advancement of ovarian cancer producing various angiogenic factors.
Takahashi Y; Saga Y; Koyanagi T; Takei Y; Machida S; Taneichi A; Mizukami H; Sato Y; Matsubara S; Fujiwara H
Cancer Sci; 2016 May; 107(5):629-37. PubMed ID: 26893100
[TBL] [Abstract][Full Text] [Related]
65. "NEPP" peritoneal dialysis regimen has beneficial effects on plasma CEL and 3-DG, but not pentosidine, CML, and MGO.
le Poole CY; van Ittersum FJ; Valentijn RM; Teerlink T; Lindholm B; Ter Wee PM; Schalkwijk CG
Perit Dial Int; 2012; 32(1):45-54. PubMed ID: 21632443
[TBL] [Abstract][Full Text] [Related]
66. Peritoneal fibrosis and high transport are induced in mildly pre-injured peritoneum by 3,4-dideoxyglucosone-3-ene in mice.
Yokoi H; Kasahara M; Mori K; Kuwabara T; Toda N; Yamada R; Namoto S; Yamamoto T; Seki N; Souma N; Yamaguchi T; Sugawara A; Mukoyama M; Nakao K
Perit Dial Int; 2013; 33(2):143-54. PubMed ID: 23123666
[TBL] [Abstract][Full Text] [Related]
67. Inhibition of EZH2 suppresses peritoneal angiogenesis by targeting a VEGFR2/ERK1/2/HIF-1α-dependent signaling pathway.
Shi Y; Li J; Chen H; Hu Y; Tang L; Wang Y; Zang X; Ma X; Huang G; Zhou X; Tao M; Lv Z; Chen S; Qiu A; Zhuang S; Liu N
J Pathol; 2022 Oct; 258(2):164-178. PubMed ID: 35792675
[TBL] [Abstract][Full Text] [Related]
68. Bicarbonate/lactate dialysis solution improves in vivo function of peritoneal host defense in rats.
Pawlaczyk K; Kuzlan-Pawlaczyk M; Wieczorowska-Tobis K; Polubinska A; Wisniewska J; Faict D; Holmes CJ; Breborowicz A
Perit Dial Int; 1999; 19 Suppl 2():S370-7. PubMed ID: 10406549
[TBL] [Abstract][Full Text] [Related]
69. RasGRP1 is a target for VEGF to induce angiogenesis and involved in the endothelial-protective effects of metformin under high glucose in HUVECs.
Xu J; Liu M; Yu M; Shen J; Zhou J; Hu J; Zhou Y; Zhang W
IUBMB Life; 2019 Sep; 71(9):1391-1400. PubMed ID: 31120617
[TBL] [Abstract][Full Text] [Related]
70. LHT7, a chemically modified heparin, inhibits multiple stages of angiogenesis by blocking VEGF, FGF2 and PDGF-B signaling pathways.
Chung SW; Bae SM; Lee M; Al-Hilal TA; Lee CK; Kim JK; Kim IS; Kim SY; Byun Y
Biomaterials; 2015 Jan; 37():271-8. PubMed ID: 25453957
[TBL] [Abstract][Full Text] [Related]
71. Cyclooxygenase-2 and vascular endothelial growth factor expressions are involved in ultrafiltration failure.
Guo J; Xiao J; Gao H; Jin Y; Zhao Z; Jiao W; Liu Z; Zhao Z
J Surg Res; 2014 May; 188(2):527-536.e2. PubMed ID: 24559584
[TBL] [Abstract][Full Text] [Related]
72. Shear stress-stimulated endothelial cells induce smooth muscle cell chemotaxis via platelet-derived growth factor-BB and interleukin-1alpha.
Dardik A; Yamashita A; Aziz F; Asada H; Sumpio BE
J Vasc Surg; 2005 Feb; 41(2):321-31. PubMed ID: 15768016
[TBL] [Abstract][Full Text] [Related]
73. Glucose degradation products (GDP) retard remesothelialization independently of D-glucose concentration.
Morgan LW; Wieslander A; Davies M; Horiuchi T; Ohta Y; Beavis MJ; Craig KJ; Williams JD; Topley N
Kidney Int; 2003 Nov; 64(5):1854-66. PubMed ID: 14531821
[TBL] [Abstract][Full Text] [Related]
74. Neutral solution low in glucose degradation products is associated with less peritoneal fibrosis and vascular sclerosis in patients receiving peritoneal dialysis.
Kawanishi K; Honda K; Tsukada M; Oda H; Nitta K
Perit Dial Int; 2013; 33(3):242-51. PubMed ID: 23123670
[TBL] [Abstract][Full Text] [Related]
75. bFGF and PDGF-BB have a synergistic effect on the proliferation, migration and VEGF release of endothelial progenitor cells.
Sufen G; Xianghong Y; Yongxia C; Qian P
Cell Biol Int; 2011 May; 35(5):545-51. PubMed ID: 20961291
[TBL] [Abstract][Full Text] [Related]
76. Endothelial progenitor cells induce a phenotype shift in differentiated endothelial cells towards PDGF/PDGFRβ axis-mediated angiogenesis.
Wyler von Ballmoos M; Yang Z; Völzmann J; Baumgartner I; Kalka C; Di Santo S
PLoS One; 2010 Nov; 5(11):e14107. PubMed ID: 21124835
[TBL] [Abstract][Full Text] [Related]
77. Epithelial to mesenchymal transition as a triggering factor of peritoneal membrane fibrosis and angiogenesis in peritoneal dialysis patients.
Aguilera A; Yáñez-Mo M; Selgas R; Sánchez-Madrid F; López-Cabrera M
Curr Opin Investig Drugs; 2005 Mar; 6(3):262-8. PubMed ID: 15816502
[TBL] [Abstract][Full Text] [Related]
78. Pyridoxal phosphate and hepatocyte growth factor prevent dialysate-induced peritoneal damage.
Nakamura S; Niwa T
J Am Soc Nephrol; 2005 Jan; 16(1):144-50. PubMed ID: 15563557
[TBL] [Abstract][Full Text] [Related]
79. Glucose degradation products downregulate ZO-1 expression in human peritoneal mesothelial cells: the role of VEGF.
Leung JC; Chan LY; Li FF; Tang SC; Chan KW; Chan TM; Lam MF; Wieslander A; Lai KN
Nephrol Dial Transplant; 2005 Jul; 20(7):1336-49. PubMed ID: 15814533
[TBL] [Abstract][Full Text] [Related]
80. Inhibition of protein kinase C enhances angiogenesis induced by platelet-derived growth factor C in hyperglycemic endothelial cells.
Moriya J; Ferrara N
Cardiovasc Diabetol; 2015 Feb; 14():19. PubMed ID: 25849290
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
